nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A population-based analysis of statin utilization in British Columbia
|
Raymond, Colette B. |
|
2007 |
29 |
9 |
p. 2107-2119 13 p. |
artikel |
2 |
A randomized, double-blind, placebo-controlled, two-period, crossover, pilot trial of lamotrigine in patients with central pain due to multiple sclerosis
|
Breuer, Brenda |
|
2007 |
29 |
9 |
p. 2022-2030 9 p. |
artikel |
3 |
Assessing compliance, acceptance, and tolerability of teriparatide in patients with osteoporosis who fractured while on antiresorptive treatment or were intolerant to previous antiresorptive treatment: An 18-month, multicenter, open-label, prospective study
|
Adachi, Jonathan D. |
|
2007 |
29 |
9 |
p. 2055-2067 13 p. |
artikel |
4 |
A 24-week, multicenter, randomized, double-blind, placebo-controlled, parallel-group study of the efficacy and tolerability of combination therapy with rosiglitazone and sulfonylurea in african american and hispanic american patients with type 2 diabetes inadequately controlled with sulfonylurea monotherapy
|
Davidson, Jaime A. |
|
2007 |
29 |
9 |
p. 1900-1914 15 p. |
artikel |
5 |
A 6-Week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%
|
Maul, Eugenio |
|
2007 |
29 |
9 |
p. 1915-1923 9 p. |
artikel |
6 |
Comprehensive review of rasagiline, a second-generation monoamine oxidase inhibitor, for the treatment of Parkinson's Disease
|
Chen, Jack J. |
|
2007 |
29 |
9 |
p. 1825-1849 25 p. |
artikel |
7 |
Cost-effectiveness of pegaptanib compared to photodynamic therapy with verteporfin and to standard care in the treatment of subfoveal wet age-related macular degeneration in Canada
|
Earnshaw, Stephanie R. |
|
2007 |
29 |
9 |
p. 2096-2106 11 p. |
artikel |
8 |
Desloratadine treatment for intermittent and persistent allergic rhinitis: A review
|
Bachert, Claus |
|
2007 |
29 |
9 |
p. 1795-1802 8 p. |
artikel |
9 |
Dosing intervals and hemoglobin control in patients with chronic kidney disease and anemia treated with epoetin alfa or darbepoetin alfa: A retrospective cohort study
|
Nurko, Saul |
|
2007 |
29 |
9 |
p. 2010-2021 12 p. |
artikel |
10 |
Effectiveness of erdosteine in elderly patients with bronchiectasis and hypersecretion: A 15-day, prospective, parallel, open-label, pilot study
|
Crisafulli, Ernesto |
|
2007 |
29 |
9 |
p. 2001-2009 9 p. |
artikel |
11 |
Effects of liposomal amphotericin B versus an amphotericin B lipid complex on liver histopathology in patients with hematologic malignancies and invasive fungal infections: A retrospective, nonrandomized autopsy study
|
Chamilos, Georgios |
|
2007 |
29 |
9 |
p. 1980-1986 7 p. |
artikel |
12 |
Effects of renin-angiotensin system inhibition end-organ protection: Can we do better?
|
Weir, Matthew R. |
|
2007 |
29 |
9 |
p. 1803-1824 22 p. |
artikel |
13 |
Effects of risedronate 5 mg/d on bone mineral density and bone turnover markers in late-postmenopausal women with osteopenia: A multinational, 24-month, randomized, double-blind, placebo-controlled, parallel-group, phase III trial
|
Välimäiki, Matti J. |
|
2007 |
29 |
9 |
p. 1937-1949 13 p. |
artikel |
14 |
Evaluation of the bioequivalence of single 100-mg doses of two oral formulations of cyclosporin a microemulsion: A randomized, open-label, two-period crossover study in healthy adult male mexican volunteers
|
Piñeyro-López, Alfredo |
|
2007 |
29 |
9 |
p. 2049-2054 6 p. |
artikel |
15 |
Full results of the Evidence of Interferon Dose-Response-European North American Comparative Efficacy (EVIDENCE) study: A multicenter, randomized, assessor-blinded comparison of low-dose weekly versus high-dose, high-frequency interferon β-1a for relapsing multiple sclerosis
|
Schwid, Steven R. |
|
2007 |
29 |
9 |
p. 2031-2048 18 p. |
artikel |
16 |
Nelarabine: A novel purine antimetabolite antineoplastic agent
|
Buie, Larry W. |
|
2007 |
29 |
9 |
p. 1887-1899 13 p. |
artikel |
17 |
Oromucosal Δ9-tetrahydrocannabinol/cannabidiol for neuropathic pain associated with multiple sclerosis: An uncontrolled, open-label, 2-year extension trial
|
Rog, David J. |
|
2007 |
29 |
9 |
p. 2068-2079 12 p. |
artikel |
18 |
Pharmacokinetic and pharmacodynamic properties of a single intravenous dose of ibutilide fumarate: A phase I, randomized, open-label, increasing-dose study in healthy chinese men
|
Li, Yishi |
|
2007 |
29 |
9 |
p. 1957-1966 10 p. |
artikel |
19 |
Pharmacokinetics and tolerability of rabeprazole sodium in subjects aged 12 to 16 years with gastroesophageal reflux disease: An open-label, single- and multiple-dose study
|
James, Laura |
|
2007 |
29 |
9 |
p. 2082-2092 11 p. |
artikel |
20 |
Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years
|
Kisicki, James C. |
|
2007 |
29 |
9 |
p. 1967-1979 13 p. |
artikel |
21 |
Pooled analysis of two clinical trials comparing the clinical outcomes of topical ciprofloxacin/dexamethasone otic suspension and polymyxin B/neomycin/hydrocortisone otic suspension for the treatment of acute otitis externa in adults and children
|
Rahman, Ateequr |
|
2007 |
29 |
9 |
p. 1950-1956 7 p. |
artikel |
22 |
Posaconazole: An extended-spectrum triazole antifungal agent
|
Schiller, Daryl S. |
|
2007 |
29 |
9 |
p. 1862-1886 25 p. |
artikel |
23 |
Public administration and public policy: Is pharmacoeconomic evidence considered in decisions on pharmaceutical policy?
|
Lyles, Alan |
|
2007 |
29 |
9 |
p. 2094-2095 2 p. |
artikel |
24 |
Ranibizumab for the treatment of neovascular age-related macular degeneration: A review
|
Kourlas, Helen |
|
2007 |
29 |
9 |
p. 1850-1861 12 p. |
artikel |
25 |
Results of a phase III, 8-week, multicenter, prospective, randomized, double-blind, parallel-group clinical trial to assess the effects of amlodipine camsylate versus amlodipine besylate in korean adults with mild to moderate hypertension
|
Kim, Sang-Hyun |
|
2007 |
29 |
9 |
p. 1924-1936 13 p. |
artikel |
26 |
Risk reduction and tolerability of fluvastatin in patients with the metabolic syndrome: A pooled analysis of thirty clinical trials
|
Winkler, Karl |
|
2007 |
29 |
9 |
p. 1987-2000 14 p. |
artikel |